Longitudinal tumor ecosystem mapping defines glioblastoma treatment trajectories

preprint OA: closed
Full text JSON View at publisher
Full text 2,070 characters · extracted from oa-doi-fallback · click to expand
Longitudinal tumor ecosystem mapping defines glioblastoma treatment trajectories Abstract Glioblastoma remains an invariably recurring and lethal brain tumor shaped by complex interactions between malignant and microenvironmental cells. How these interactions evolve under first-line standard-of-care (SOC) therapy remains unclear. We performed spatial single-cell profiling of 671 paired newly diagnosed and recurrent glioblastoma samples from 96 patients to map tumor-ecosystem evolution and its clinical relevance. We delineated five distinct patient subgroups, each characterized by unique ecosystem trajectories that correlated with clinical outcome. Patients whose tumors transitioned into oligodendrocyte-progenitor-like niches with enhanced vascular integrity, oxygenation and an IL10/CCL/MHCII immunomodulatory environment experienced improved clinical prognosis. In contrast, progression towards hypoxic mesenchymal/astrocyte-like niches dominated by strong LGALS1/SPP1/TGFß immunosuppression predicted poor outcome. Furthermore, a subgroup of early-relapsing patients on SOC therapy that was characterized by a depletion of an antigen-presenting myeloid-cell-rich niche, exhibited diminished responsiveness to second-line lomustine therapy. Overall, mapping evolutions in glioblastoma ecosystems offers a novel framework for prognostic stratification and therapeutic guidance. Competing Interest Statement The authors have declared no competing interest. Subject Area - Biochemistry (17695) - Bioengineering (13894) - Bioinformatics (41946) - Biophysics (21454) - Cancer Biology (18591) - Cell Biology (25506) - Clinical Trials (138) - Developmental Biology (13379) - Ecology (19901) - Epidemiology (2067) - Evolutionary Biology (24320) - Genetics (15609) - Genomics (22508) - Immunology (17736) - Microbiology (40394) - Molecular Biology (17182) - Neuroscience (88607) - Paleontology (667) - Pathology (2832) - Pharmacology and Toxicology (4824) - Physiology (7641) - Plant Biology (15156) - Synthetic Biology (4296) - Systems Biology (9825) - Zoology (2271)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00